Send to a friend

The details you provide on this page will not be used to send unsolicited email, and will not be sold to a 3rd party. See privacy policy.

Economic constraints often cause developing countries to hold back on developing novel technologies. But many argue that taking advantage of the current window of opportunity to develop genomic medicine will contribute to economic growth and social welfare.

In this article, Gerardo Jimenez-Sanchez of Johns Hopkins University Mexico outlines plans to develop a genomic programme in Mexico that focuses on national health problems. The plans, which include establishing an Institute of Genomic Medicine, are being developed by a consortium of leading Mexican scientific and health institutes.

The consortium has already established three new graduate courses in genomic medicine at the National Autonomous University of Mexico, and aims to get the Mexican Institute of Genomic Medicine off the ground by the end of this year.

Link to article in Science

Reference: Science 300, 295 (2003)